Form D — Psy Therapeutics, Inc.

0001410578-25-002156 · filed Sep 12, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry: Pharmaceuticals
Exemptions: 06b
Reported offering amount: $20,400,000
Reported amount sold: $6,762,848
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Psy Therapeutics, Inc.
CIK: 1788222
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 28 ATLANTIC AVE, SUITE 222
BOSTON, MA 02110
Phone: (617) 723-5429

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

David S. Barlow · Executive Officer

Boston, MA Find on LinkedIn ↗
Jeff Troderman · Executive Officer

Boston, MA Find on LinkedIn ↗
Alan Cross · Director

Boston, MA Find on LinkedIn ↗
Daniel Weiss Pick · Director

Boston, MA Find on LinkedIn ↗
Jerry F. Rosenbaum · Director

Boston, MA Find on LinkedIn ↗
William Wagner · Executive Officer

Boston, MA Find on LinkedIn ↗
Paul Murphy · Director

Boston, MA Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗